Navigation Links
Sinovac Reports Unaudited Second Quarter 2011 Financial Results
Date:8/12/2011

We anticipate that the Certificate of Approval for Anflu will be granted in the coming months as we prepare for the commercial launch of the vaccine in Mexico."

Dr. Yin concluded, "We are encouraged by the second quarter sales activity and public market orders received in recent months.  We believe that the ongoing execution of our revised sales strategy and seasonal flu vaccine sales that typically take place in the second half of the year will enable continued revenue growth. We look forward to updating you on the continued progress across our vaccine development pipeline."

Financial Review for the Second Quarter Ended June 30, 2011 Sales for the second quarter 2011 were $15.7 million, up 52.5% from $10.3 million for the second quarter of 2010. During the second quarter 2011, Sinovac recorded $7.7 million in pandemic influenza vaccine sales on prior year order.

Sinovac's sales breakdown by product was as follows.Three months ended June 30,2011

2010SalesHepatitis vaccines

$8,097,941

$8,676,883Influenza vaccines

7,558,158

1,586,823Total

$ 15,656,099

$ 10,263,706Gross profit for the second quarter 2011 was $10.8 million, with a gross margin of 68.8%, compared to $8.5 million and a gross margin of 82.7% for the same period of 2010.  After deducting depreciation of land use rights and amortization of licenses and permits, the gross margin was 67.9% and 81.7% for the second quarter of 2011 and 2010, respectively. The gross profit margin was adversely affected by the revenue recognition in the second quarter 2011 of the prior pandemic flu vaccine order that had a lower gross margin than other vaccine products.

Selling, general and administrative expenses for the second quarter 2011 were $5.0 million, compared to $4.0 million in the same period of 2010. SG&A expenses as a percentage of second quarter 2011 sales were 31.8%, compared to 38.9% during the second quarter of the pr
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Sinovac Announces Management Changes
2. Sinovac Holds 2011 Annual Shareholders Meeting
3. Sinovac Appoints Kenneth Lee to Board of Directors
4. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
5. Sinovac Reports Unaudited First Quarter 2011 Financial Results
6. Sinovac Presents at Two Investor Conferences in May 2011
7. Sinovac Files Annual Report on Form 20-F
8. Sinovac Participates in UBS Greater China Healthcare Corporate Day
9. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
10. Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
11. Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... SAN DIEGO , July 30, 2015 ... announced it has signed a definitive agreement ... provider of non-invasive ventilation and sleep-disordered breathing ... strong clinical, innovation and market reputation in China, combined with ResMed,s global leadership ... of people in China ...
(Date:7/30/2015)... 2015  EP Global Communications, Inc. (Public OTC: EPGL) announced ... the Company about discussing EPGL,s electronic contact lens ... August 3, 2015.  Novartis CEO Joe Jimenez ... coming electronic contact lens market could be worth ... several years.  Novartis partnered with Google in 2014 ...
(Date:7/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) ... of 2015. Key results include: , Total ... of 2014 to $5,370 million, with 6 percent ... (etanercept), Prolia ® (denosumab), Sensipar ® ... ® (denosumab). Unfavorable changes in foreign exchange ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23
... Calif., Feb. 25, 2011 Accuray Incorporated ... the field of radiosurgery, announced today that its Senior Vice ... was named "Best General Counsel, Small Public Company" by the ... San Francisco Business Times as part of their ,Best ...
... Landauer, Inc. (NYSE: LDR ) announced today that ... $0.55 per share for the second quarter of fiscal 2011.  The ... record on March 11, 2011. About Landauer ... analytical services to determine occupational and environmental radiation exposure and is ...
Cached Medicine Technology:Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award 2Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award 3Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award 4
(Date:7/30/2015)... ... July 30, 2015 , ... The ... BioPharma, Inc. are pleased to announce that data standards for clinical research in ... on the CDISC website . These three Therapeutic Area (TA) standards were ...
(Date:7/30/2015)... ... July 30, 2015 , ... In an effort to provide ... Aggarwal is making a change in his practice. , The decision will also allow ... 2015, Dr. Aggarwal will be transferring his in-patient admissions to the hospitalists at East ...
(Date:7/30/2015)... ... July 30, 2015 , ... Women's dating ... Lines ." It's for women interested in improving their love lives using specific ... which officially launched to the public early this morning, has drawn praise from ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... In a ... clients at Serenity Palms Drug Addiction Treatment Center have created an addiction graveyard. Sharing ... one of its most beloved residents, Rocky Hudson . Hudson (1945-2015) fell in ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... is the recipient of three awards in the Service Industry Advertising Awards 12th ... for Choptank Transport, KRM Development Corporation and University of Maryland Shore Regional Health. ...
Breaking Medicine News(10 mins):Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 3Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 3
... the all-natural weight management program, opened in Ottawa with the ... began their weight-loss journey on the Smart for Life(TM) program ... for 6 family members. As friends and relatives joined the ... exciting business opportunity. , "Smart for Life(TM) is ...
... and services company focused on global eClinical solutions for the clinical ... studies from European Sponsor clients. These new studies will seek to ... as the Indian subcontinent. , "We ... to be a direct result of our continued hard work in ...
... ... and CEO of Abraxis Health, will receive the Adaptive Business Leaders Organization,s 2009 ... Awards Event on October 28, in Newport Beach. , ... Santa Ana, CA (PRWEB) October ...
... ... launch of their "Tats for Tatas" fundraising campaign that will take place ... the company,s concerted efforts to raise awareness and funds for Breast Cancer ... the company will be donating 10% of all proceeds from sales throughout ...
... Pa., Oct. 15 Herley Industries, Inc. (Nasdaq: HRLY ... Fiscal Year ended August 2, 2009. , Fourth Quarter ... quarter of fiscal 2009 were $43.0 million compared to $37.9 ... fourth quarter of fiscal 2009, the Company recorded several significant ...
... Minnesota Nurses Point to Benefits for Patients, Nurse Staffing and ... A new Senate bill introduced today by Sen. Al ... of RNs in hospitals and other health care facilities, but ... transported and moved in the safest way possible, all while ...
Cached Medicine News:Health News:Smart for Life(TM) Center Opens in Ottawa 2Health News:DATATRAK Announces the Award of New Studies from European Pharmaceutical Clients 2Health News:DATATRAK Announces the Award of New Studies from European Pharmaceutical Clients 3Health News:Patrick Soon-Shiong, World Renowned Healthcare Visionary & Philanthropist, to Receive ABL's Leadership Award & Make Keynote Presentation, October 28, in Newport Beach 2Health News:Patrick Soon-Shiong, World Renowned Healthcare Visionary & Philanthropist, to Receive ABL's Leadership Award & Make Keynote Presentation, October 28, in Newport Beach 3Health News:Patrick Soon-Shiong, World Renowned Healthcare Visionary & Philanthropist, to Receive ABL's Leadership Award & Make Keynote Presentation, October 28, in Newport Beach 4Health News:Atomic Tattoos Announces "Tats for Tatas" October Fundraising Event to Benefit Local Breast Cancer Research 2Health News:Herley Reports Fourth Quarter and Year-End Results 2Health News:Herley Reports Fourth Quarter and Year-End Results 3Health News:Herley Reports Fourth Quarter and Year-End Results 4Health News:Herley Reports Fourth Quarter and Year-End Results 5Health News:Herley Reports Fourth Quarter and Year-End Results 6Health News:Herley Reports Fourth Quarter and Year-End Results 7Health News:Herley Reports Fourth Quarter and Year-End Results 8Health News:Herley Reports Fourth Quarter and Year-End Results 9Health News:Herley Reports Fourth Quarter and Year-End Results 10Health News:Herley Reports Fourth Quarter and Year-End Results 11Health News:Herley Reports Fourth Quarter and Year-End Results 12Health News:Nation's RNs Hail Sen. Franken's Support for Safe Patient Handling Measure 2
... opticians in a store environment. Optizone ... retail store industry by opticians. Optizone ... for Optizone 2000. It is written ... User friendly screen interfaces make learning ...
This product offers patient, product and practice cash management to ease the strain of practice administration....
... MaximEyes by First Insight is the ... records solution for eye care professionals. ... with Eyefinitys online servicesrequest VSP authorizations, ... MaximEyes offers EMR, scheduling, billing, demographics, ...
... software for eyecare professionals- Winx ... multi-office practice management system, using ... Winx Pro is a complete ... in effectively managing the administrative, ...
Medicine Products: